On ECHEMI
Home > Drugs > Hubei Sihuan Pharmaceutical Co., Ltd.
Hubei Sihuan Pharmaceutical Co., Ltd.
  • Founded in:

    2002-09-02
  • Country:

    China China
  • Address:

    Room C6321, Building C6, No. 666 Gaoxin Avenue, East Lake New Technology Development Zone, Wuhan City, Hubei Province
  • Tax NO.:

    914200007417627664
  • Registered Funds:

    45 million yuan
  • Website:

  • Email:

Related Drugs
Trimetazidine Hydrochloride Tablets
The active ingredient of this product is trimetazidine hydrochloride, its chemical name: 1-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride, molecular formula: C14H22N2O3.2HCL molecular weight: 339.3
Name Description Content CAS NO. Registered Holders
Trimetazidine dihydrochloride

By protecting the energy metabolism of cells under hypoxia or ischemia, preventing the decrease of intracellular ATP levels, it ensures the normal function of ion pumps and the normal operation of transmembrane sodium-potassium flow, and maintains the stability of the intracellular environment. It helps maintain the energy metabolism of the heart and nerve sensory organs under ischemia and hypoxia, reduces intracellular acidosis and changes in transmembrane ion flow caused by ischemia, reduces the movement and infiltration of multinuclear neutrophils during ischemia and myocardial reperfusion, and reduces the scope of experimental infarction. While producing this effect, it has no significant effect on hemodynamics. It increases coronary blood flow reserve, delays the occurrence of exercise-induced ischemia, limits rapid fluctuations in blood pressure without significant changes in heart rate, significantly reduces the frequency of angina attacks, and significantly reduces the use of glyceryl trinitrate.

More

By protecting the energy metabolism of cells under hypoxia or ischemia, preventing the decrease of intracellular ATP levels, it ensures the normal function of ion pumps and the normal operation of transmembrane sodium-potassium flow, and maintains the stability of the intracellular environment. It helps maintain the energy metabolism of the heart and nerve sensory organs under ischemia and hypoxia, reduces intracellular acidosis and changes in transmembrane ion flow caused by ischemia, reduces the movement and infiltration of multinuclear neutrophils during ischemia and myocardial reperfusion, and reduces the scope of experimental infarction. While producing this effect, it has no significant effect on hemodynamics. It increases coronary blood flow reserve, delays the occurrence of exercise-induced ischemia, limits rapid fluctuations in blood pressure without significant changes in heart rate, significantly reduces the frequency of angina attacks, and significantly reduces the use of glyceryl trinitrate.

13171-25-0 31
Ranitidine Hydrochloride Tablets
The main ingredient of this product is: Ranitidine hydrochloride. Its chemical name is: N'-methyl-N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]-methyl]thio]ethyl]-2-nitro-1,1-ethylenediamine hydrochloride. Molecular formula: C13H22N4O3SHCl Molecular weight: 350.87
Name Description Content CAS NO. Registered Holders
Ranitidine Hydrochloride

This product is an H2 receptor inhibitor, which has the effect of inhibiting gastric acid secretion. It is rapidly absorbed through the gastrointestinal tract after oral administration.

More

This product is an H2 receptor inhibitor, which has the effect of inhibiting gastric acid secretion. It is rapidly absorbed through the gastrointestinal tract after oral administration.

66357-59-3 49
Bifonazole suppository
Contains bifonazole.
Name Description Content CAS NO. Registered Holders
Bifonazole

This product is a broad-spectrum antifungal drug, which has antibacterial effects on dermatophytes and Candida. Its mechanism of action is to inhibit the synthesis of bacterial cell membranes.

More

This product is a broad-spectrum antifungal drug, which has antibacterial effects on dermatophytes and Candida. Its mechanism of action is to inhibit the synthesis of bacterial cell membranes.

60628-96-8 11
Levofloxacin lactate
Name Description Content CAS NO. Registered Holders
LEVOFLOXACIN LACTATE

294662-18-3 11
Ipriflavone
Name Description Content CAS NO. Registered Holders
Ipriflavone

Extract from the above information

More

Extract from the above information

35212-22-7 2
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.